Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 887998 | ISIN: US6245801062 | Ticker-Symbol: MV4
Stuttgart
17.01.25
11:47 Uhr
18,100 Euro
0,000
0,00 %
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
MOVADO GROUP INC Chart 1 Jahr
5-Tage-Chart
MOVADO GROUP INC 5-Tage-Chart
RealtimeGeldBriefZeit
18,50018,60019:54
18,50018,60019:54
PR Newswire
138 Leser
Artikel bewerten:
(0)

Movado Group, Inc.: Movado Partners With Derrick Adams to Unveil New Artist Series Collection

Finanznachrichten News

Exclusive collaboration highlights Adams' vision of the black experience through contemporary cubism and Movado's iconic Museum Dial with limited edition watches, clocks and collectors set

PARAMUS, N.J., Jan. 17, 2025 /PRNewswire/ -- Movado Group, Inc. (NYSE: MOV) is proud to announce its new Artist Series collaboration with Derrick Adams, a multidisciplinary artist, and one of the leading black artists of the 21st century. This collaboration celebrates the Black experience, employing vibrant and joyous colors by pairing iconic design with contemporary cubism. Adams has held several solo exhibitions at institutions across the country, including The Cleveland Museum of Art, The Momentary, Crystal Bridges Museum of American Art, Hudson River Museum, and the Museum of Arts and Design.

Derrick Adams X Movado: Floater Wall Clock

Movado's Artist Series reflects four decades of collaborations with world renowned artists, including Andy Warhol, James Rosenquist, and Carmen Herrera, to craft curated collections that represent wearable works of art. For this collaboration, Movado will feature a limited-edition collection that pairs Derrick Adams' vibrant pieces and singular style with Movado's iconic Museum Dial- - translating his strong command of texture and passion for color onto each piece.

"We are excited to partner with Derrick Adams on this unique partnership, which blends timeless craftsmanship with his visionary artistry," said Efraim Grinberg, Chairman and CEO, Movado Group. "At Movado, we've always believed that a great watch is not just a tool to tell time, but also a work of art that tells a story. This partnership brings together our legacy of precision and luxury with Derrick Adams' unmatched creativity and expression. We're thrilled to offer this exclusive collection to our consumers and collectors worldwide."

"It's been a pleasure to collaborate with such a forward-thinking team at Movado, and I'm incredibly proud of what we've created together," said Derrick Adams. "Time, much like art, is something we experience, interpret, and cherish in unique ways, and each watch represents not just the passage of time, but moments of inspiration and individuality. The watches in this collection were designed with the same level of dedication and attention to detail as a gallery piece, and I wanted to ensure each one felt personal for its wearer. For me, it's about producing something that lasts, resonates and captures the essence of who we are at this moment in time, and Movado's watches exemplify this concept to the fullest."

Within the Artist Series, the resulting designs are true collectors items - watches as wearable art and gallery-worthy wall clocks. The exclusive Derrick Adams X Movado limited edition collection includes five watches in the series with 125 pieces of each design including a total of 25 collectors sets. All watches are individually numbered on the caseback. This is the first time Movado and an artist have designed a clock in an Artist Series collaboration. Two of the five watch designs were transformed into a wall clock; 125 of each clock are available for purchase. Five collectors sets and 20 of each of the wall clocks were donated to the Studio Museum of Harlem by Derrick Adams and Movado.

About Derrick Adams:
Derrick Adams is a multidisciplinary artist living and working in Brooklyn, New York and one of the leading Black artists of the 21st century. Adams' art celebrates the Black experience, employing vibrant colors and a?contemporary-cubist style that draws on the richness of Black culture. He received his BFA from Pratt Institute, New York, in 1996 and graduated with an MFA from Columbia University, New York, in 2003. In addition to his critically acclaimed art practice, Adams has held numerous teaching positions and is currently a tenured assistant professor in the School of Visual, Media and Performing Arts at CUNY Brooklyn College. He also holds an honorary doctorate from Maryland Institute College of Art.

About Movado Group:
Movado Group, Inc. designs, sources, and globally distributes and sells MOVADO®, MVMT®, OLIVIA BURTON®, EBEL®, CONCORD®, CALVIN KLEIN®, COACH®, TOMMY HILFIGER®, HUGO BOSS®, and LACOSTE® watches and, to a lesser extent, jewelry and other accessories, and operates Movado Company Stores in the United States and Canada.

Contact for Movado Group, Inc.:
Heather Cohen Sugarman
Hcohen@movadogroup.com
Vice President, Public Relations

Derrick Adams X Movado: Collector's Set

Derrick Adams X Movado: Arting Watch

Photo - https://mma.prnewswire.com/media/2598986/Derrick_Adams_X_Movado_Floater_Wall_Clock.jpg
Photo - https://mma.prnewswire.com/media/2598987/Derrick_Adams_X_Movado_Collectors_Set.jpg
Photo - https://mma.prnewswire.com/media/2598988/Derrick_Adams_X_Movado_Arting_Watch.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/movado-partners-with-derrick-adams-to-unveil-new-artist-series-collection-302352400.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.